Abstract
Identification of potential druggable targets utilizing protein-protein interactions network (PPIN) has been emerging as a hotspot in drug discovery and development research. However, it remains unclear whether the currently used PPIN topological properties are enough to discriminate the drug targets from non-drug targets. In this study, three-step classification models using different network topological properties were designed and implemented using support vector machine (SVM) to compare the enrichment of known drug targets from non-targets. Surprisingly, none of the models was able to identify more than 75% of the true targets in the test set. It appears that the currently used simple PPIN topological properties are not likely robust enough for prediction of potential drug targets with high confidence, which also echoes similarly unsatisfying prediction data reported previously. However, we proposed that quality and quantity improvement of the protein-protein interactions (PPI) data for model training will help increasing the prediction accuracy.
Keywords: Drug targets, protein-protein interactions network, support vector machine, network topological properties.
Combinatorial Chemistry & High Throughput Screening
Title:Are Topological Properties of Drug Targets Based on Protein-Protein Interaction Network Ready to Predict Potential Drug Targets?
Volume: 19 Issue: 2
Author(s): Shiliang Li, Xiaojuan Yu, Chuanxin Zou, Jiayu Gong and Xiaofeng Liu
Affiliation:
Keywords: Drug targets, protein-protein interactions network, support vector machine, network topological properties.
Abstract: Identification of potential druggable targets utilizing protein-protein interactions network (PPIN) has been emerging as a hotspot in drug discovery and development research. However, it remains unclear whether the currently used PPIN topological properties are enough to discriminate the drug targets from non-drug targets. In this study, three-step classification models using different network topological properties were designed and implemented using support vector machine (SVM) to compare the enrichment of known drug targets from non-targets. Surprisingly, none of the models was able to identify more than 75% of the true targets in the test set. It appears that the currently used simple PPIN topological properties are not likely robust enough for prediction of potential drug targets with high confidence, which also echoes similarly unsatisfying prediction data reported previously. However, we proposed that quality and quantity improvement of the protein-protein interactions (PPI) data for model training will help increasing the prediction accuracy.
Export Options
About this article
Cite this article as:
Li Shiliang, Yu Xiaojuan, Zou Chuanxin, Gong Jiayu and Liu Xiaofeng, Are Topological Properties of Drug Targets Based on Protein-Protein Interaction Network Ready to Predict Potential Drug Targets?, Combinatorial Chemistry & High Throughput Screening 2016; 19 (2) . https://dx.doi.org/10.2174/1386207319666151110122145
DOI https://dx.doi.org/10.2174/1386207319666151110122145 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Alkaptonuria, Ochronosis and Ochronotic Arthropathy in Mainland France and the Reunion Island. A Report of Clinical and Molecular Findings in 29 Patients
Current Rheumatology Reviews Lipid Matrix Nanoparticles: Pharmacokinetics and Biopharmaceutics
Current Nanoscience Radiopharmaceutical: Revolutionary Agents for Diagnosis
Current Radiopharmaceuticals Flavones as a Privileged Scaffold in Drug Discovery: Current Developments
Current Organic Synthesis Neopterin as a Marker for Immune System Activation
Current Drug Metabolism Modern Developments in the Spray-Drying Industries
Recent Patents on Materials Science The Importance of NAD in Multiple Sclerosis
Current Pharmaceutical Design Current Therapeutics, Their Problems and Thiol Metabolism as Potential Drug Targets in Leishmaniasis
Current Drug Metabolism Mechanisms of Neutrophil-mediated Disease: Innovative Therapeutic Interventions
Current Pharmaceutical Design Key Sites for P2X Receptor Function and Multimerization: Overview of Mutagenesis Studies on a Structural Basis
Current Medicinal Chemistry The Role of Electrospinning in the Emerging Field of Nanomedicine
Current Pharmaceutical Design Heart Failure in Sub-Saharan Africa
Current Cardiology Reviews Biomarkers in the Diagnosis of Ventilator-Associated Pneumonia
Current Respiratory Medicine Reviews Patenting of Nanopharmaceuticals in Drug Delivery: No Small Issue
Recent Patents on Drug Delivery & Formulation Therapies in Development for Non-Infectious Uveitis
Current Molecular Medicine Molecular Biological Roles of Ursolic Acid in the Treatment of Human Diseases
Current Bioactive Compounds The Use of Nitric Oxide Synthase Inhibitors in Inflammatory Diseases: A Novel Class of Anti-Inflammatory Agents
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Fatty Acids - Induced Lipotoxicity and Inflammation
Current Drug Metabolism Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery
Current Drug Research Reviews Does the Immune System Regulate Mood to Defend against Infection? Evidence from Studies of Immune Factors, Depression, and Antidepressants
Current Psychiatry Reviews